The short version
14 companies supply this market — deep enough that no single failure threatens the supply. The price has jumped 49% in a year, to $0.9309 per mL — sharp rises like this often mean supply is already tightening. It is in shortage right now. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.